Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRamsdens Hldgs Regulatory News (RFX)

Share Price Information for Ramsdens Hldgs (RFX)

Share Price is delayed by 15 minutes
Get Live Data
587.00    -5.00 (-0.84%)
Bid:
580.00
Ask:
594.00
Spread: 14.00 (2.414%)
Market Cap: £189.93m
RFX Live PriceLast checked at - London Stock Exchange

Intraday Ramsdens Hldgs Share Chart

Form 8.3 - "RAMSDENS HOLDINGS PLC"

Today 09:20

RNS Number : 5608J
Oddo BHF AIF PLC
24 June 2026
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Oddo BHF AIF PLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

RAMSDENS HOLDINGS PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

23/06/2026

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

1p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

759 617

2.35%

 

 

(2) Cash-settled derivatives:

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

TOTAL:

759 617

2.35%

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

1p ordinary

Purchase

759 617

590.0569 GBp

 

 (b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 (c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

none

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

none

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

24/06/2026

Contact name:

Névine ZEMMOURI

 

+33 1 44 51 85 22

controleaif@oddo-bhf.com

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETFIMPTMTBTMRF
Date   Source Headline
24th Jun 202612:38 pmGNWForm 8.3 - Ramsdens Holdings Plc
24th Jun 202611:09 amRNSForm 8.5 (EPT/NON-RI) Ramsdens Holdings Plc
24th Jun 202611:03 amRNSForm 8.3 - Ramsdens Holdings Plc
24th Jun 202610:58 amRNSForm 8.3 - Ramsdens Holdings plc
24th Jun 20269:33 amRNSForm 8.5 (EPT/NON-RI)
24th Jun 20269:20 amRNSForm 8.3 - "RAMSDENS HOLDINGS PLC"
23rd Jun 20267:45 amRNSDisclosure Table
23rd Jun 20267:00 amRNSRECOMMENDED ACQUISITION OF RAMSDENS HOLDINGS PLC
3rd Jun 20267:00 amRNSInterim Results - six months ended 31 March 2026
6th May 20267:00 amRNSTrading Update
7th Apr 20262:54 pmRNSDirector/PDMR Shareholding
7th Apr 202611:54 amRNSDirector/PDMR Shareholding
18th Mar 20267:00 amRNSTrading Update
9th Mar 20263:38 pmRNSResult of AGM
9th Mar 20263:38 pmRNSResult of AGM
12th Feb 20261:45 pmRNSHolding(s) in Company
10th Feb 20267:00 amRNSTrading Update
23rd Jan 20267:00 amRNSNotice of AGM
14th Jan 20267:00 amRNSAnnual Results - year ended 30 September 2025
7th Jan 20267:00 amRNS-RNotice of Annual Results Investor Presentation
12th Dec 20257:00 amRNSAppointment of Nominated Adviser and Broker
24th Nov 20257:00 amRNSDirector/PDMR Shareholding
17th Nov 202510:08 amRNSDirector/PDMR Shareholding
3rd Nov 20257:00 amRNS-RNotice of Investor Presentation
8th Oct 20257:00 amRNSPre-Close Trading Update
10th Sep 20252:17 pmRNSHolding(s) in Company
21st Aug 20259:35 amRNSHolding(s) in Company
19th Jun 202510:47 amRNSHolding(s) in Company
18th Jun 20257:00 amRNSDirector/PDMR Shareholding
4th Jun 20257:00 amRNSInterim Results - six months ended 31 March 2025
16th May 20257:00 amRNSNotice of Interim Results & Investor Presentation
2nd May 20257:00 amRNSDirector/PDMR Shareholding
28th Apr 20252:54 pmRNSHolding(s) in Company
24th Apr 20259:47 amRNSDirector/PDMR Shareholding
8th Apr 20257:00 amRNSTrading Update
17th Mar 20254:05 pmRNSChange of Registered Office Address
14th Mar 20253:21 pmRNSDirector/PDMR Shareholding
13th Mar 202510:58 amRNSCSOP update
3rd Mar 20254:27 pmRNSResult of AGM
3rd Mar 20257:00 amRNSAGM Business Update
29th Jan 20257:00 amRNSIssue of Equity, PDMR and Total Voting Rights
23rd Jan 202512:46 pmRNSNotice of AGM
14th Jan 20257:00 amRNSAnnual Results - year ended 30 September 2024
28th Oct 20243:55 pmRNSHolding(s) in Company
11th Oct 20244:31 pmRNSHolding(s) in Company
10th Oct 20247:00 amRNSPre-Close Trading Update and Notice of Results
8th Oct 20247:00 amRNSDirector/PDMR Shareholding
1st Oct 20247:00 amRNSAppointment of Non-Executive Director
8th Aug 20247:00 amRNSDirector/PDMR Shareholding
6th Aug 20247:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.